Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials? - Zackova, Daniela; Klamova, Hana; Dusek, Ladislav; Muzik, Jan; Polakova, Katerina Machova; Moravcova, Jana; Jurcek, Tomas; Dvorakova, Dana; Racil, Zdenek; Pospisil, Zdenek; Oltova, Alexandra; Michalova, Kyra; et al. (American journal of hematology, 2011)
Keywords: sběr dat; Piperazines; Humans; Data Collection; mužské pohlaví; pyrimidiny; Imatinib Mesylate; Treatment Outcome; Female; výsledek terapie; hodnocení léčiv; Leukemia, Myeloid, Chronic-Phase; Male; imatinib mesylát; Czech Republic; chronická fáze myeloidní leukemie; Drug Evaluation; benzamidy; Benzamides; Česká republika; ženské pohlaví; Pyrimidines; lidé; piperaziny